Last reviewed · How we verify
Calcium carbonate tablets
Calcium carbonate tablets is a Mineral supplement / Calcium salt Small molecule drug developed by Chinese SLE Treatment And Research Group. It is currently FDA-approved for Calcium deficiency / hypocalcemia, Bone health support in systemic lupus erythematosus (SLE), Osteoporosis prevention and treatment.
Calcium carbonate provides supplemental calcium ions to correct hypocalcemia and support bone mineralization.
Calcium carbonate is a small molecule used in the treatment of various conditions, including osteoporosis, postmenopausal osteoporosis, and castrate-resistant prostate cancer with bone metastasis. It is also studied for its potential effects on cognitive change, cardiovascular disease, and other conditions.
At a glance
| Generic name | Calcium carbonate tablets |
|---|---|
| Sponsor | Chinese SLE Treatment And Research Group |
| Drug class | Mineral supplement / Calcium salt |
| Modality | Small molecule |
| Therapeutic area | Rheumatology / Bone Health / Nutritional Supplementation |
| Phase | FDA-approved |
Mechanism of action
Calcium carbonate is an inorganic salt that dissociates in the acidic environment of the stomach to release calcium ions, which are absorbed in the small intestine. It serves as a calcium supplement to treat or prevent calcium deficiency states, support bone health, and may have adjunctive roles in managing conditions like systemic lupus erythematosus (SLE) where bone loss is a concern. The drug does not have a specific molecular target but rather acts as a nutritional/mineral replacement agent.
Approved indications
- Calcium deficiency / hypocalcemia
- Bone health support in systemic lupus erythematosus (SLE)
- Osteoporosis prevention and treatment
Common side effects
- Constipation
- Nausea
- Abdominal discomfort
- Hypercalcemia (with excessive intake)
Key clinical trials
- PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition (PHASE2)
- Combined Effects of Statins and Exercise on Training Sensitive Health Markers (NA)
- Quality of Life in Diarrhea-predominant Irritable Bowel Syndrome Taking GABA (NA)
- Calcium Carbonate on Labor Induction (NA)
- Evaluate the Pharmacokinetics of Oral Arsenic Trioxide Solution Under Fasting and Fed Conditions, to Compare Intravenous Arsenic Trioxide, in Acute Promyelocytic Leukemia (PHASE1)
- Evaluating the Safety and Efficacy of AMOR-1 as a Treatment for Hypocalcemia Associated With Hypoparathyroidism in Adults (PHASE2)
- Phase II Study of Ovulation in Obese Women (PHASE2)
- CARDIA-Salt Sensitivity of Blood Pressure (SSBP) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Calcium carbonate tablets CI brief — competitive landscape report
- Calcium carbonate tablets updates RSS · CI watch RSS
- Chinese SLE Treatment And Research Group portfolio CI
Frequently asked questions about Calcium carbonate tablets
What is Calcium carbonate tablets?
How does Calcium carbonate tablets work?
What is Calcium carbonate tablets used for?
Who makes Calcium carbonate tablets?
What drug class is Calcium carbonate tablets in?
What development phase is Calcium carbonate tablets in?
What are the side effects of Calcium carbonate tablets?
Related
- Drug class: All Mineral supplement / Calcium salt drugs
- Manufacturer: Chinese SLE Treatment And Research Group — full pipeline
- Therapeutic area: All drugs in Rheumatology / Bone Health / Nutritional Supplementation
- Indication: Drugs for Calcium deficiency / hypocalcemia
- Indication: Drugs for Bone health support in systemic lupus erythematosus (SLE)
- Indication: Drugs for Osteoporosis prevention and treatment
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing